About 62,193 results

ALLMedicine™ Rheumatoid Arthritis Center

Research & Reviews  18,699 results

Combining current knowledge on DNA methylation-based age estimation towards the develop...
Forensic Science International. Genetics; Aliferi A, Sundaram S et. al.

Dec 3rd, 2021 - The estimation of chronological age from biological fluids has been an important quest for forensic scientists worldwide, with recent approaches exploiting the variability of DNA methylation patterns with age in order to develop the next generatio...

Predictors of interest in predictive testing for rheumatoid arthritis amongst first deg...
Rheumatology (Oxford, England); Wells I, Zemedikun DT et. al.

Dec 2nd, 2021 - There is increasing interest in prediction and prevention of rheumatoid arthritis (RA). It is important to understand the views of those at risk to inform the development of effective approaches. First-degree relatives (FDRs) of RA patients are at...

Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degrada...
Rheumatology (Oxford, England); Hosoya T, Saito T et. al.

Dec 2nd, 2021 - Targeting synovial fibroblasts (SF) using a cyclin-dependent kinase (CDK) 4/6 inhibitor (CDKI) could be a potent therapy for rheumatoid arthritis (RA) via inhibition of proliferation and MMP-3 production. This study was designed to elucidate the m...

Analgesia Prescribing in Patients with Inflammatory Arthritis in England: An Observatio...
Rheumatology (Oxford, England); Scott IC, Bailey J et. al.

Dec 2nd, 2021 - International data suggest inflammatory arthritis (IA) pain management frequently involves opioid prescribing, despite little evidence of efficacy, and potential harms. We evaluated analgesia prescribing in English National Health Service-managed ...

see more →

Guidelines  31 results

EULAR points to consider for conducting clinical trials and observational studies in in...
Annals of the Rheumatic Diseases; Mankia K, Siddle HJ et. al.

Aug 8th, 2021 - Despite growing interest, there is no guidance or consensus on how to conduct clinical trials and observational studies in populations at risk of rheumatoid arthritis (RA). An European League Against Rheumatism (EULAR) task force formulated four r...

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis & Rheumatology (Hoboken, N.J.); Fraenkel L, Bathon JM et. al.

Jun 9th, 2021 - To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grad...

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis Care & Research; Fraenkel L, Bathon JM et. al.

Jun 9th, 2021 - To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grad...

Clinical Practice Guideline for Physical Therapist Management of People With Rheumatoid...
Physical Therapy; Peter WF, Swart NM et. al.

May 19th, 2021 - This guideline revises the 2008 Royal Dutch Society for Physical Therapy guideline for physical therapy for patients with rheumatoid arthritis (RA). This revised guideline was developed according to the Appraisal of Guidelines for Research and Eva...

The significance of the low sex ratios of offspring and of sibs of probands with system...
Early Human Development; James WH, Grech V

Sep 8th, 2019 - There is good evidence that there are significantly low sex ratios (proportions male) in the offspring of patients with some immune diseases e.g. systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). There is also strong evidence that ...

see more →

Drugs  1,765 results see all →

Clinicaltrials.gov  942 results

Gene Expression in Chronic Venous Leg Ulcers

Nov 25th, 2021 - Chronic Venous Disease (CVD) is a widespread clinical condition widely spread in the western countries, with a prevalence ranging from 10% in adults younger than 30 years of age to nearly 80% for individuals >70 years of age. CVD clinical manifest...


Nov 24th, 2021 - A longitudinal open-label study that will include individuals who will receive the ChAdOx1 nCoV-19 vaccine (AZD1222), in a standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccinati...

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

Nov 24th, 2021 - RA is a chronic autoimmune inflammatory disorder of unknown etiology that occurs in approximately 1 percent (%) of the population. Nipocalimab (also referred to as JNJ-80202135 and M281) is a fully human aglycosylated immunoglobulin (Ig)G1 monoclo...

Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX

Nov 22nd, 2021 - The product FBL-MTX consists of Methotrexate (MTX) encapsulating liposomes functionalized with a folate peptide (SP-DS3), which targets activated macrophages of rheumatoid arthritis (RA). This is a prospective, single-center, randomized, double-bl...

see more →

News  3,383 results

No impact of anti-inflammatory diet on health-related quality of life in RA

Dec 1st, 2021 - Key clinical point: The anti-inflammatory diet did not enhance health-related quality of life in patients with rheumatoid arthritis (RA) compared with a control diet. However, physical functioning improved significantly, particularly in patients w.

Sinusitis and upper respiratory tract diseases may increase the risk for rheumatoid arthritis

Dec 1st, 2021 - Key clinical point: Sinusitis, pharyngitis, and acute respiratory burden all raised the likelihood of developing rheumatoid arthritis (RA). Major finding: Acute sinusitis (odds ratio [OR], 1.

Obesity, depression, anxiety, and illness beliefs influence remission, pain, and fatigue in RA

Dec 1st, 2021 - Key clinical point: Obesity, anxiety, depression, and illness perception at baseline were associated with treatment outcomes, pain, and fatigue in patients with rheumatoid arthritis (RA). Major finding: At 12 months , obesity vs.

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion

Nov 17th, 2021 - WASHINGTON (Reuters) - Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday. AbbVie ...

Tofacitinib Postmarketing Data Shed Light on JAK Inhibitor Risks

Nov 17th, 2021 - Additional analyses of a postmarketing trial that was required after the Food and Drug Administration's approval of the Janus kinase inhibitor tofacitinib (Xeljanz, Xeljanz XR) has identified characteristics of older patients with rheumatoid arthr...

see more →

Patient Education  57 results see all →